SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-21-001242
Filing Date
2021-02-18
Accepted
2021-02-18 08:15:08
Documents
2
Period of Report
2021-02-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1711
2 POA poa_lzumwalt.txt EX-24 3484
  Complete submission text file 0001562180-21-001242.txt   6652
Mailing Address C/O THE ADVISORY BOARD CO WATERGATGE 600 NEW HAMPSHIRE AVE NW WASHINGTON DC 20037
Business Address
ZUMWALT LEANNE M (Reporting) CIK: 0001204946 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36352 | Film No.: 21647717

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations